12
February/March 2019 Laboratory Focus www.laboratoryfocus.ca
NEW PRODUCTS GORE® Carotid Stent The FDA has approved the GORE® Carotid Stent for market. The stent is designed to re-open narrowed regions of the carotid arteries in the neck that supply blood to the brain. Made of nickel-titanium alloy (nitinol) tubing laser-cut into a mesh shape, the stent is placed in the body with a tube in the leg then advanced up to the neck. The GORE® Carotid Stent is intended to be used with the GORE® Embolic Filter in patients who have had a recent stroke and have a moderate blockage of at least 50 per cent of the blood vessels of the neck, have a high likelihood of complications due to other medical problems, or have large blockages (80 per cent or more) of the vessels in the neck. The stent opens blockages to prevent future strokes, but should not be used in patients who: • Are allergic to nitinol or heparin, • Have blockages at the beginning of the neck artery, • Cannot take blood thinners or have bleeding disorders, • Have other problems that may prevent the GORE® Embolic Filter from being placed properly, or • Have problems that prevent the GORE® Carotid Stent catheter from getting to the blockage.
https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm626637.htm
Biological safety cabinets
PolarSafe® ethylene vinyl acetate (EVA) ice buckets and pans
New PolarSafe® EVA ice buckets and pans provide mess-free benchtop cryogenic chilling. Made from EVA, a thick non-toxic foam, these buckets and pans don’t sweat or leak, making them perfect for use with ice, dry ice, liquid nitrogen, alcohol and saline solutions. Other features of PolarSafe®’s buckets and pans include: • A variety of sizes and colours, • Convenient pour spouts for easy use and cleanup, • Stackable construction for neat and compact storage, and • Ergonomic handles on the base and lids make them easy to use with cryogenic gloves. PolarSafe® buckets and pans are created by Cole-Parmer Canada, a leading global source of laboratory and industrial fluid handling products, instrumentation, equipment and supplies since 1955.
https://www.coleparmer.ca/p/polarsafe-eva-ice-buckets/72830
MediBeacon’s transdermal GFR monitor
New biological safety cabinets from the biomedical division of Panasonic Healthcare (PHCbi) have completed PHCbi’s life sciences product line up. Safety is ensured through PHCbi’s laminar airflow control system which includes a specially designed electronically commutated high efficiency motor with speed control. The blower in the cabinets was strategically chosen to provide proper face velocity while compensating for filter loading and voltage variations resulting in consistent distribution of downflow air to prevent uneven filter loading. Biological safety cabinets by PHCbi are ideal for moderate risk hazard areas in research, drug preparation and product operation. Energy saving cell culture hoods operate at a lower speed when night mode is enabled, allowing for energy conservation while maintaining containment. PHCbi biological safety cabinet features include: • Five-year parts and labour warranty, • Compliant with NSF/ANSI 49 UL/UL-C, • Ringback warnings on airflow and sash opening arms, • Ergonomic design for easy accessibility to the work area, • Ability to accommodate a variety of decontamination processes, • Front filter removal for easy filter exchange by certified technicians, and • Eye level microprocessor with digital display for control over all functions.
https://www.phchd.com
MediBeacon is providing a better way to track kidney function via its glomerular filtration rate (GFR) measurement system. The GFR monitor is a non-invasive monitoring technology that uses a light sensor placed on the skin (like pulse oximetry). The sensor works in conjunction with a proprietary biocompatible tracer to monitor real-time point of care kidney function, enabling earlier detection of renal issues and earlier, more effective treatments. The tracer agent (MB-102) is pyrazine-based small molecule and has been used as a tracer agent in animal studies with no adverse reactions for up to 300 times the estimated human dose. Patents have been executed or are pending by MediBeacon. A monitor of this nature optimizes kidney care while minimizing the risk of renal failure and the need for dialysis or transplant. Earlier release from hospital is also possible if renal function is shown to be normal via the GFR monitor even if serum creatine isn’t back to normal.
https://www.medibeacon.com
